Kiromic furloughs 'substantially all' workers amid cash crunch, leaving 31 staff without pay
Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has stopped paying the employees, which make up “substantially all” of its workforce, until it raises money to ease its cash crisis.
